These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 33980166)

  • 1. Reversible renal-limited thrombotic microangiopathy due to gemcitabine-dexamethasone-cisplatin therapy: a case report.
    Nishikubo M; Shimomura Y; Hiramoto N; Sawamura N; Yamaguchi T; Hara S; Ishikawa T
    BMC Nephrol; 2021 May; 22(1):175. PubMed ID: 33980166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine-induced thrombotic microangiopathy with nephrotic syndrome.
    Katagiri D; Hinoshita F
    CEN Case Rep; 2018 Nov; 7(2):217-220. PubMed ID: 29766468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of eculizumab in gemcitabine induced thrombotic microangiopathy.
    Krishnappa V; Gupta M; Shah H; Das A; Tanphaichitr N; Novak R; Raina R
    BMC Nephrol; 2018 Jan; 19(1):9. PubMed ID: 29329518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Detection of Urinary Podocytes from Drug-Induced Glomerular Thrombotic Microangiopathy in Advanced Cancer Patients.
    Usui J; Yokoyama C; Hagiwara M; Hirayasu K; Kojima T; Yoshino T; Nishiyama H; Hara M; Yamagata K
    Clin Lab; 2016 Dec; 62(12):2413-2417. PubMed ID: 28164557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gemcitabine-induced thrombotic microangiopathy.
    Richmond J; Gilbar P; Abro E
    Intern Med J; 2013 Nov; 43(11):1240-2. PubMed ID: 24237646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombotic Microangiopathy Following Chemotherapy with S-1 and Cisplatin in a Patient with Gastric Cancer: A Case Report.
    Muto J; Kishimoto H; Kaizuka Y; Kinjo M; Higashi H; Kishihara F
    In Vivo; 2017; 31(3):439-441. PubMed ID: 28438876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre.
    Grall M; Daviet F; Chiche NJ; Provot F; Presne C; Coindre JP; Pouteil-Noble C; Karras A; Guerrot D; François A; Benhamou Y; Veyradier A; Frémeaux-Bacchi V; Coppo P; Grangé S
    BMC Nephrol; 2021 Jul; 22(1):267. PubMed ID: 34284729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort.
    Daviet F; Rouby F; Poullin P; Moussi-Francès J; Sallée M; Burtey S; Mancini J; Duffaud F; Sabatier R; Pourroy B; Grandvuillemin A; Grange S; Frémeaux-Bacchi V; Coppo P; Micallef J; Jourde-Chiche N
    Br J Clin Pharmacol; 2019 Feb; 85(2):403-412. PubMed ID: 30394581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine-related thrombotic microangiopathy: a single-centre retrospective series.
    Leal F; Macedo LT; Carvalheira JB
    J Chemother; 2014 Jun; 26(3):169-72. PubMed ID: 24091354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic microangiopathy, cancer, and cancer drugs.
    Izzedine H; Perazella MA
    Am J Kidney Dis; 2015 Nov; 66(5):857-68. PubMed ID: 25943718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal thrombotic microangiopathy and podocytopathy associated with the use of carfilzomib in a patient with multiple myeloma.
    Hobeika L; Self SE; Velez JC
    BMC Nephrol; 2014 Sep; 15():156. PubMed ID: 25267524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature.
    Usui J; Glezerman IG; Salvatore SP; Chandran CB; Flombaum CD; Seshan SV
    Hum Pathol; 2014 Sep; 45(9):1918-27. PubMed ID: 25087655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study.
    Camilleri M; Cuadrado M; Phillips E; Wilson W; Jenner R; Pang G; Kamora S; Streetly M; Popat R; Bygrave C; Owen R; Cavenagh J; Chapman M; Sive J; Eccersley L; Sheaff M; Benjamin R; Ramasamy K; Cook G; Virchis A; Chavda SJ; Clifton-Hadley L; Scully MA; Yong K
    Br J Haematol; 2021 May; 193(4):750-760. PubMed ID: 33650100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pegylated Liposomal Doxorubicin Causes Kidney-limited Thrombotic Microangiopathy.
    Glezerman I; Salvatore S; Tap W; Kelly C; Brauer Ornelas CM; Shaikh A
    Am J Kidney Dis; 2024 Apr; 83(4):549-553. PubMed ID: 37839689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinine-Induced Thrombotic Microangiopathy: A Report of 19 Patients.
    Page EE; Little DJ; Vesely SK; George JN
    Am J Kidney Dis; 2017 Nov; 70(5):686-695. PubMed ID: 28780041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild forms of thrombotic microangiopathy in patients with advanced pancreatic cancer receiving gemcitabine and nab-paclitaxel.
    Garcia de Herreros M; Esposito F; Sauri T; Font C
    J Oncol Pharm Pract; 2023 Apr; 29(3):738-745. PubMed ID: 35876362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microangiopathy associated with gemcitabine: a drug interaction with nab-paclitaxel? A case series and literature review.
    Allard J; Bonnet M; Laurent L; Bouattour M; Gagaille MP; Leclerc V
    Eur J Clin Pharmacol; 2022 Jul; 78(7):1087-1093. PubMed ID: 35507073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid Improvement in Gemcitabine-associated Thrombotic Microangiopathy After a Single Dose of Eculizumab: Case Report and Review of the Literature.
    Burns ST; Damon L; Akagi N; Laszik Z; Ko AH
    Anticancer Res; 2020 Jul; 40(7):3995-4000. PubMed ID: 32620643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory secondary thrombotic microangiopathy with kidney injury associated with systemic lupus erythematosus in a pediatric patient.
    Kaneda T; Tanaka E; Akutsu Y; Kanamori T; Mouri M; Morio T; Mori M
    CEN Case Rep; 2020 Nov; 9(4):301-307. PubMed ID: 32304042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of thrombotic microangiopathy during chemotherapy with gemcitabine in a patient with pancreatic cancer].
    Kashima H; Minami R; Ozawa T; Matsumoto A; Kimura Y; Takeda Y; Ueo T; Okano A; Kusumi F; Ohana M
    Nihon Shokakibyo Gakkai Zasshi; 2022; 119(3):259-266. PubMed ID: 35264490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.